Patients Stopping Weight-Loss Injections Regain Weight at a Quadrupled Rate Compared to People Using Diet and Exercise

New research reveals that people who stop using blockbuster weight-loss injections like Wegovy and Mounjaro can put back on shed pounds far faster than those who end traditional lifestyle plans.

Research printed in a leading health publication shows that while obese individuals often shed about a fifth of their total mass while on the medication, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.

"Individuals using these drugs should be aware of the danger of rapid rebound weight gain when the medication concludes," cautioned researcher Dr. Susan Jebb.

That rate of regain means a reversion to starting weight in about 18 months.

Analyzing Approaches

The analysis, which examined 37 of studies involving thousands of patients, compared the results of the injectable medications with older methods.

The team point out that individuals who lose weight through lifestyle changes alone typically experience a less rapid weight regain—perhaps 100 grams monthly—post-intervention.

Explaining the Rapid Regain

Doctors believe the mechanism of the jabs accounts for the amplified weight return.

The injections mimic a body's own chemical called GLP-1, which moderates hunger.

"Sustained high doses of GLP-1 concentrations far above than the body's typical production could lead to the system to produce less of its own natural GLP-1, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this hormone supplement means hunger is uncontrolled, making binge eating a significant risk."

A Chronic Condition?

The NHS recommend the injections for people with weight-linked health risks, alongside prescribed lifestyle changes.

Many experts contend that, considering the significant potential of relapse, the therapy is often life-long.

This opinion is echoed by pharmaceutical companies, who note that the results "emphasize the long-term nature of obesity," comparing it to managing diseases like hypertension.

Patient Testimonies

People who have discontinued the jabs describe a intense return of hunger.

"I experienced something flipping and you become ravenous," said one woman.

The struggle is worsened if patients have not adopted sustainable lifestyle or habit modifications during treatment.

Significant Interest

Survey data indicate that millions of people in the UK have used weight-loss jabs in the past year, with demand continuing to grow.

• Adoption is greater among women compared to males.
• The 40s and 50s age group shows the highest level of interest.
• A large proportion access the drugs through private prescriptions rather than the NHS.

In conclusion, clinicians caution that while these medications are powerful agents for weight loss, they are not a magic cure and long-term success likely depends on combined lifestyle management.